Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOMILNACIPRAN Cause Grip strength decreased? 66 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Grip strength decreased have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 4.8% of all adverse event reports for LEVOMILNACIPRAN.

66
Reports of Grip strength decreased with LEVOMILNACIPRAN
4.8%
of all LEVOMILNACIPRAN reports
66
Deaths
66
Hospitalizations

How Dangerous Is Grip strength decreased From LEVOMILNACIPRAN?

Of the 66 reports, 66 (100.0%) resulted in death, 66 (100.0%) required hospitalization, and 66 (100.0%) were considered life-threatening.

Is Grip strength decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 66 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOMILNACIPRAN Cause?

Off label use (376) Drug ineffective (315) Gastrooesophageal reflux disease (295) Vomiting (294) Hypoaesthesia (290) Abdominal pain upper (285) Paraesthesia (282) Memory impairment (277) Blepharospasm (276) Taste disorder (276)

What Other Drugs Cause Grip strength decreased?

ADALIMUMAB (2,317) METHOTREXATE (2,271) ETANERCEPT (2,018) RITUXIMAB (1,597) TOCILIZUMAB (1,537) LEFLUNOMIDE (1,492) HYDROXYCHLOROQUINE (1,476) DICLOFENAC (1,473) SULFASALAZINE (1,409) SECUKINUMAB (1,408)

Which LEVOMILNACIPRAN Alternatives Have Lower Grip strength decreased Risk?

LEVOMILNACIPRAN vs LEVONORGESTREL LEVOMILNACIPRAN vs LEVORPHANOL LEVOMILNACIPRAN vs LEVOSIMENDAN LEVOMILNACIPRAN vs LEVOSULPIRIDE LEVOMILNACIPRAN vs LEVOTHYROXINE

Related Pages

LEVOMILNACIPRAN Full Profile All Grip strength decreased Reports All Drugs Causing Grip strength decreased LEVOMILNACIPRAN Demographics